Skip to content

8-KAccepted Nov 16, 7:05 AM ET

Xtant Medical: reports 3rd quarter 2026 results and board-led strategic review

XTNTXtant Medical Holdings, Inc.

Accepted (ET)

7:05 AM

Nov 16, 2026

Filed

Nov 16, 2026

Documents

13

Size

424.7 KB

Summary

Xtant Medical: reports 3rd quarter 2026 results and board-led strategic review

Updated

What happened On Nov 16, 2026, Xtant Medical Holdings, Inc. announced its financial results for the 3rd quarter of 2026. The company furnished a press release as Exhibit 99.1 to the Form 8-K. The press release was titled "Xtant Medical reports 3rd quarter 2026 financial results and announces board-led strategic review process."

Key details

  • Form 8-K filed on Nov 16, 2026 reporting results of operations and financial condition under Item 2.02.
  • Press release furnished as Exhibit 99.1 and dated Nov 16, 2026.
  • The press release title references a board-led strategic review process.
  • The filing includes the cover page interactive data file (Exhibit 104) embedded in the Inline XBRL document.

Why it may matter The filing reported Item 2.02 (results of operations and financial condition), which covers the company’s reported financial results. This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing